Page 100 - Sohini Das

Homebuyers tilt towards branded players despite slowdown in real estate mkt

According to PropEquity, 600 mn sq ft of projects at a pan-Indian level are stuck. This accounts for 50 per cent of the unsold inventory in terms of units

Indian pharmaceutical companies spread business to avoid regulatory ire

Increased USFDA import alerts could be reason for finding alternative sites

Cipla looks at digital media for expanding footprint and reach customers

The pharma major looks to expand its footprint by driving up the diagnosis around diseases, uses digital media to take the brand directly to the end-user

Digital to be 50% of our India business, says Ketchum Global CEO

The global chief executive officer (CEO) also indicated there were no plans to merge the Omnicom Group's PR networks in India unlike what it did in Singapore and some European countries

Bills for pills: Antibiotics could be govt's next segment for price cap

Centre likely to consider rationalising trade margins

India's leading drugmakers stocking up to avoid supply disruptions

Have increased raw material buffer stock by at least 40 days in recent months

Maharashtra govt plans to deliver emergency medicines through drones

Zipline drones will make on-demand and emergency deliveries of blood products, vaccines and life-saving medications

Pharma PSUs likely to sign MoU with LMA for sale of surplus land

The PSUs thus are hopeful that the sale process could now be expedited

Anti-tuberculosis drug market continues to shrink for private firms

Lupin, the largest player in India's anti-TB market, too admitted that in anti-TB segment, the focus on branded business has declined in the past few years

Airtel Africa's mobile money, data growth to double by 2024: Experts

The operator continues to invest in the 4G network, having added nearly 1,500 sites

Lupin divests its Japanese injectables business to Abu Dhabi company

Company is looking at enhancing efficiencies in Japanese market which is facing pricing pressure

Airtel Africa data and mobile money penetration to double in next 5 years

Airtel is preparing for the launch of the Mobile Money business in Nigeria

Fortis files suit to recover Rs 520 crore from Malvinder, Shivinder Singh

In October, the Sebi had directed Fortis to take necessary action to recover Rs 403 cr from Singh brothers

Glenmark plans to divest non-core global assets to reduce debt by Rs 800 cr

Apart from rationalising costs, the company is also aiming to divest some of its non-core global assets as well as bring in a minority investor in to Glenmark Life Sciences

Vodafone Idea needs to raise operational expenses savings target: Analysts

Reacting to the weak June quarter numbers, the firm's shares tanked 27 per cent on Monday, eroding over Rs 7,000 crore from its market valuation

Journey of Reliance Jio: From disrupting telecom to becoming the king

The youngest operator took 3 years to claim the top spot, changing the industry in the process

Torrent Pharmaceuticals manages to improve Unichem's FY19 profits

Losar comprised almost 20% of the acquired portfolio of Unichem

Drug major GSK sold off up to 10 tail-end brands in FY19 including Celin

According to the firm's FY19 annual report, it fetched Rs 5 crore during the year from the sale of brands

From Celin to Septran, GSK Pharma sold 8-10 tail-end brands in FY19

The firm's FY19 annual report shows that it fetched Rs 5 crore during the year from the sale of brands

It's time for India's one-brand pharma firms to scale up, diversify

Many of these brands are not protected against the discovery a new, more efficient molecule as the small firms that own them have not kept pace with the latest research